Evaluation of dual pathology among drug-resistant epileptic patients with hippocampal sclerosis
- 42 Downloads
Dual pathology (DP) is defined as simultaneous presence of hippocampal sclerosis (HS) and any other pathology in the brain. Since this is a less probed concept, we aimed to evaluate the frequency and characteristics of DP among drug-resistant epileptic patients with HS.
This is a cross-sectional study conducted during 2007–2016 in Kashani Comprehensive Epilepsy Center, Isfahan, Iran. Patients with diagnosis of drug-resistant epilepsy and HS were enrolled in the study, and demographic data, seizure semiology, EEG findings, and MRI findings were collected. We compared these variables between three groups of DP, unilateral HS, and bilateral HS.
Of the 200 enrolled cases, 29 patients (14.5%) had DP and 21 patients (10.5%) had bilateral HS; the remaining patients had unilateral HS. The average age of patients with DP was 30.03, and 65.5% of them were male. Patients with DP had more EEG discharges from regional and multi-focal sites compared to unilateral HS (P value < 0.001). Also, complex partial seizure (CPS) was more commonly presented in patients with unilateral HS (96.8%). Comparison of disease characteristics between DP and bilateral HS showed no difference in most categories (P > 0.05).
We found DP among 14.5% of our drug-resistant epileptic patients with HS. DP patients mostly presented with CPS and had high proportion of ictal and interictal EEG discharges from regional and multi-focal areas. Gliosis and focal cortical dysplasia were the most common pathologies among DP patients. Patients with DP showed a similar behavior to bilateral HS in many features.
KeywordsHippocampal sclerosis Dual pathology Drug-resistant epilepsy Mesial temporal sclerosis
We wish to thank vice-chancellor for research and technology of Isfahan University of Medical Sciences for supporting and funding this project (grant number 394004).
- 4.Bouchet C, Cazauvieilh J (1825) De l’épilepsie considérée dans ses rapports avec l’aliénation mentale. Arch Gen Med 9:510–542Google Scholar
- 6.Téllez-Zenteno JF, Hernández-Ronquillo L (2011) A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res Treat 2012Google Scholar
- 9.Kuzniecky RI, Knowlton RC Neuroimaging of epilepsy. In: Semin Neurol, 2002. vol 03. Copyright© 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.:+ 1 (212) 584–4662, pp 279–288Google Scholar
- 11.Wyllie E, Cascino GD, Gidal BE, Goodkin HP (2012) Wyllie's treatment of epilepsy: principles and practice. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
- 17.Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51(6):1069–1077PubMedCrossRefGoogle Scholar
- 20.Cendes F, Theodore WH, Brinkmann BH, Sulc V, Cascino GD (2016) Neuroimaging of epilepsy. In: Handbook of clinical neurology, vol 136. Elsevier, pp 985–1014Google Scholar